Valeant nabs OraPharma; GSK get MenHibrix OK'd; Trajenta into India;

@FiercePharma: NICE tells Roche Zelboraf is too expensive. More | Follow @FiercePharma

> Canadian drugmaker Valeant Pharmaceuticals International, has agreed to pay $312 million upfront and up to $114 million more in constancy payments to buy OraPharma, a specialty oral health company. Announcement

> GlaxoSmithKline ($GSK) has gotten FDA approval for its vaccine MenHibrix, to be used to treat the rare but sometimes fatal disease Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b, in children 6 weeks through 18 months. Release

> Teva ($TEVA) has introduced into the U.K., (Oroeze) Benzydamine 0.15% w/v Oromucosal spray, an analgesic used in tonsillectomies or dental surgery. Item

> Boehringer Ingelheim and Eli Lilly ($LLY) say they will begin selling Trajenta in India for Type 2 diabetes. Item

>The FDA is supposed to decide this week if it will approve Pfizer's drug for treating patients with TTR-FAP, a disease which starts with tingling in the feet and advances upward killing nerves and then patients within a decade. Story

> Feds nail Internet pharmacy operator for fake drugs. News

> HGS sets deadline for bids: Come and get it! Story

> Drugmakers line up for tsunami of diabetes. More

Biotech News

@FierceBiotech: After death, some stem cells remain alive for days. More | Follow @FierceBiotech

@RyanMFierce: Human Genome Sciences sets deadline of July 16 for acquisition offers, but not sure how that motivates non-GSK buyers. More | Follow @RyanMFierce

> Pfizer ramps up work with academics and biotech startups. Story

> HGS to GSK: Play by our buyout rules. More

> GSK grabs FDA nod for combo meningitis vax. News

> Bristol taps drug chemistry whizzes at Scripps. Article

Medical Device News

@FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

> U.K. regulators cracking down on sale of fake devices. More

> Will the device tax cost lives? Story

> FDA investigates Fresenius over kidney dialysis controversy. Article

> GAO: Orthopedic implantable device admission rates soar. More

And Finally... Amed Villa says he didn't have anything to do with the daring $80 million heist of prescription drugs from a Connecticut warehouse in 2010 and pleads not guilty. Story